XML 49 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock Plans and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Option Activity Includes Options Granted

The following table, which includes options granted under the Company’s Stock Plans, summarizes option activity:

 

 

 

Shares
Subject to
Outstanding
Options

 

 

Weighted
Average
Exercise
Price Per
Share

 

 

Weighted
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2020

 

 

9,892,697

 

 

$

13.88

 

 

 

 

 

 

 

Options granted

 

 

3,758,769

 

 

$

33.03

 

 

 

 

 

 

 

Options exercised

 

 

(680,755

)

 

$

13.68

 

 

 

 

 

 

 

Options forfeited or canceled

 

 

(950,799

)

 

$

19.08

 

 

 

 

 

 

 

Outstanding at December 31, 2021

 

 

12,019,912

 

 

$

19.46

 

 

 

8.02

 

 

$

253,620

 

Options vested and expected to vest as of December 31, 2021

 

 

12,019,912

 

 

$

19.46

 

 

 

8.02

 

 

$

253,620

 

Options exercisable as of December 31, 2021

 

 

5,158,246

 

 

$

14.55

 

 

 

7.15

 

 

$

133,742

 

T
Summary of Restricted Stock Units Activity

Restricted Stock Units

The Company grants restricted stock units (RSUs) to its employees and directors under the 2018 Plan. The shares subject to the RSUs vest annually or quarterly over four years for employees and annually for directors.

 

 

Total Restricted Stock Units

 

 

Weighted
Average
Grant Date Fair Value

 

Nonvested at December 31, 2020

 

 

738,650

 

 

$

27.84

 

RSUs granted

 

 

932,362

 

 

 

34.05

 

RSUs vested

 

 

(382,183

)

 

 

31.60

 

RSUs forfeited or canceled

 

 

(212,741

)

 

 

26.06

 

Nonvested at December 31, 2021

 

 

1,076,088

 

 

$

32.23

 

Summary of Employee and Non-Employee Stock-based Compensation Expense

The following table summarizes employee and non-employee stock-based compensation expense for the years ended December 31, 2021, 2020 and 2019, and also the allocation within the consolidated statements of operations and comprehensive loss (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

 

2019

 

Research and development

 

$

28,302

 

 

$

11,195

 

 

$

4,152

 

General and administrative

 

 

26,226

 

 

 

10,630

 

 

 

4,829

 

Total stock-based compensation

 

$

54,528

 

 

$

21,825

 

 

$

8,981

 

Schedule of Assumptions Used to Calculate Fair Value of Stock-Based Compensation The following assumptions were used to calculate the fair value of stock-based compensation for the years ended December 31, 2021, 2020, and 2019:

 

 

 

Stock Options

 

 

Year Ended December 31,

 

 

2021

 

2020

 

2019

Risk-free interest rate

 

1.0% - 1.4%

 

0.4% - 0.5%

 

1.6% - 2.3%

Expected term (in years)

 

6.02

 

6.02

 

6.02

Volatility

 

75.3% - 77.6%

 

76.5% - 78.5%

 

71.8% - 74.6%

Dividend yield

 

0%

 

0%

 

0%

 

 

 

ESPP

 

 

Year Ended December 31,

 

 

2021

 

2020

 

2019

Risk-free interest rate

 

0.0% - 0.6%

 

0.1% - 0.2%

 

1.6% - 2.3%

Expected term (in years)

 

0.5-2.0

 

0.5-2.0

 

0.5-2.0

Volatility

 

61.2% - 95.7%

 

66.6% - 136.0%

 

64.8% - 77.1%

Dividend yield

 

0%

 

0%

 

0%